TRIBE study: are all three cytotoxic drugs crucial? - Authors' reply

Lancet Oncol. 2015 Dec;16(16):e578-9. doi: 10.1016/S1470-2045(15)00416-7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bevacizumab / therapeutic use*
  • Colorectal Neoplasms / drug therapy*
  • Female
  • Humans
  • Male

Substances

  • Angiogenesis Inhibitors
  • Bevacizumab